Your browser doesn't support javascript.
loading
Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.
Weberpals, Johanne I; Pugh, Trevor J; Marco-Casanova, Paola; Goss, Glenwood D; Andrews Wright, Natalie; Rath, Prisni; Torchia, Jonathon; Fortuna, Alexander; Jones, Gemma N; Roudier, Martine P; Bernard, Laurence; Lo, Bryan; Torti, Dax; Leon, Alberto; Marsh, Kayla; Hodgson, Darren; Duciaume, Marc; Howat, William J; Lukashchuk, Natalia; Lazic, Stanley E; Whelan, Doreen; Sekhon, Harmanjatinder S.
Afiliação
  • Weberpals JI; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada.
  • Pugh TJ; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Marco-Casanova P; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.
  • Goss GD; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
  • Andrews Wright N; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Rath P; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK.
  • Torchia J; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Fortuna A; Department of Medicine, Division of Medical Oncology, University of Ottawa, Ottawa, ON, Canada.
  • Jones GN; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Roudier MP; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Bernard L; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Lo B; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Torti D; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK.
  • Leon A; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK.
  • Marsh K; Department of Obstetrics and Gynecology, University of Ottawa, Ottawa, ON, Canada.
  • Hodgson D; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
  • Duciaume M; Department of Pathology and Laboratory Medicine, The Ottawa Hospital, Ottawa, ON, Canada.
  • Howat WJ; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Lukashchuk N; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Lazic SE; Ontario Institute for Cancer Research, Toronto, ON, Canada.
  • Whelan D; Translational Medicine, R&D Oncology, AstraZeneca, Cambridge, UK.
  • Sekhon HS; Ottawa Hospital Research Institute, Ottawa, ON, Canada.
Cancer Med ; 10(9): 3045-3058, 2021 05.
Article em En | MEDLINE | ID: mdl-33811746
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Transcriptoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Outros_tipos Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Cistadenocarcinoma Seroso / Transcriptoma Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged80 Idioma: En Revista: Cancer Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá